Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > Novo Nordisk’s Ozempic and Wegovy, long in shortage, now available
Health and Wellness

Novo Nordisk’s Ozempic and Wegovy, long in shortage, now available

Last updated: November 3, 2024 8:05 pm
Share
Novo Nordisk’s Ozempic and Wegovy, long in shortage, now available
SHARE

Novo Nordisk’s popular diabetes and obesity medications, Ozempic and Wegovy, have been listed on the Food and Drug Administration’s drug shortage list for over two years. However, as of Wednesday, all doses of semaglutide, the active ingredient in these medications, are now listed as available on the FDA’s website. This development raises the possibility that the medications could soon be removed from the shortage list entirely, which could have implications for compounding pharmacies and patients who rely on compounded drugs.

Semaglutide is the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy. Different doses of semaglutide have been intermittently listed in shortage over the past two years. With all doses now marked as available, the FDA is in discussions with Novo to determine if the company can adequately meet the demand for these medications moving forward. It’s important to note that the “available” designation does not necessarily mean that the drug is no longer in shortage.

FDA spokesperson Amanda Hills stated that the agency is currently assessing whether the demand for semaglutide exceeds the available supply. The decision to remove the medication from the shortage list will depend on the outcome of these discussions between the FDA and Novo.

It’s crucial for patients and healthcare providers to stay informed about the availability of these important medications. The potential resolution of the shortage could bring relief to those who rely on Ozempic and Wegovy for managing their diabetes and obesity. As the situation evolves, it will be important to monitor updates from both Novo Nordisk and the FDA regarding the status of semaglutide and its availability in the market.

See also  The CDC is switching back to ‘monkeypox’
TAGGED:LongNordisksNovoOzempicShortageWegovy
Share This Article
Twitter Email Copy Link Print
Previous Article Affirm launches in the UK, as ‘buy now, pay later’ market faces regulatory overhaul Affirm launches in the UK, as ‘buy now, pay later’ market faces regulatory overhaul
Next Article FACT CHECK: In Presidential Debate, Harris Deflects on Border Record FACT CHECK: In Presidential Debate, Harris Deflects on Border Record
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Wexner Center Director Departs Amid Staff Complaints

The Wexner Center for the Arts, Ohio State University's contemporary art institution, has announced the…

October 29, 2025

Tom Cruise Is Refusing Ozempic Due To Drugs Hatred

Tom Cruise's Controversial Stance on Antidepressants RevisitedIt has been nearly two decades since Tom Cruise…

June 13, 2025

Blood of My Blood’ Renewed for Season 2

The highly anticipated prequel series, "Outlander: Blood of My Blood," has been officially renewed for…

June 23, 2025

Women’s college basketball debate: Which teams have a shot at winning the NCAA Tournament?

As we approach Selection Sunday, the excitement for March Madness is at an all-time high.…

March 7, 2025

10 Classy Celebrity Styles You Can Recreate This Weekend

This week’s best celebrity fashion moments have showcased a range of classy styles that are…

February 21, 2025

You Might Also Like

Digital Twins Coming To Robotic Surgery
Health and Wellness

Digital Twins Coming To Robotic Surgery

October 31, 2025
Medicare, midterm elections, Vinay Prasad: Morning Rounds
Health and Wellness

Medicare, midterm elections, Vinay Prasad: Morning Rounds

October 31, 2025
Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program, study suggests
Health and Wellness

Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program, study suggests

October 31, 2025
Once Again A Blood Pressure Medication Recall For Cancer Concerns
Health and Wellness

Once Again A Blood Pressure Medication Recall For Cancer Concerns

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?